As an oncogenic driver, MUC1 increases the aggressiveness, metastatic potential, and drug resistance of cancer by promoting tumor cell proliferation (20, 21), EMT (22), and epigenetic changes (23, 24), and facilitates immune evasion through interactions with immune cells in the tumor microenvironment (25). This evidence concerns the gene MUC1 and neoplasm.